Meningiomas are one of the most common tumors of the Central nervous system (CNS). This study aims to identify the autoantibody biomarkers in meningiomas using high-density human proteome arrays (~17,000 full-length recombinant human proteins). Screening of sera from 15 unaffected healthy individuals, 10 individuals with meningioma grade I and 5 with meningioma grade II was performed. This comprehensive proteomics based investigation revealed the dysregulation of 489 and 104 proteins in grades I and II of meningioma, respectively, along with the enrichment of several signalling pathways, which might play a crucial role in the manifestation of the disease. Autoantibody targets like IGHG4, CRYM, EFCAB2, STAT6, HDAC7A and CCNB1 were significantly dysregulated across both the grades. Further, we compared this to the tissue proteome and gene expression profile from GEO database. Previously reported upregulated proteins from meningioma tissue-based proteomics obtained from high-resolution mass spectrometry demonstrated an aggravated autoimmune response, emphasizing the clinical relevance of these targets. Some of these targets like SELENBP1 were tested for their presence in tumor tissue using immunoblotting. In the light of highly invasive diagnostic modalities employed to diagnose CNS tumors like meningioma, these autoantibody markers offer a minimally invasive diagnostic platform which could be pursued further for clinical translation.
The discovery of DNA microarrays was a major milestone in genomics; however, it could not adequately predict the structure or dynamics of underlying protein entities, which are the ultimate effector molecules in a cell. Protein microarrays allow simultaneous study of thousands of proteins/peptides, and various advancements in array technologies have made this platform suitable for several diagnostic and functional studies. Antibody arrays enable researchers to quantify the abundance of target proteins in biological fluids and assess PTMs by using the antibodies. Protein microarrays have been used to assess protein-protein interactions, protein-ligand interactions, and autoantibody profiling in various disease conditions. Here, we summarize different microarray platforms with focus on its biological and clinical applications in autoantibody profiling and PTM studies. We also enumerate the potential of tissue microarrays to validate findings from protein arrays as well as other approaches, highlighting their significance in proteomics.
Antiviral therapy is crucial for the circumvention of
viral epidemics. The
unavailability of a specific antiviral drug against the chikungunya
virus (CHIKV) disease has created an alarming situation to identify
or develop potent chemical molecules for remedial management of CHIKV.
In the present investigation, in silico
studies of dihydrorugosaflavonoid derivatives (5a–f) with non-structural protein-3 (nsP3) were carried out.
nsP3 replication protein has recently been considered as a possible
antiviral target in which crucial inhibitors fit into the adenosine-binding
pocket of the macrodomain. The 4′-halogenated dihydrorugosaflavonoids
displayed intrinsic binding with the nsp3 macrodomain (PDB ID: 3GPO)
of CHIKV. Compounds 5c and 5d showed docking
scores of −7.54 and −6.86 kcal mol–1, respectively. Various in vitro assays were performed to confirm
their (5a–f) antiviral potential
against CHIKV. The non-cytotoxic dose was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide assay and was found to be <100 μM. The compounds 5c and 5d showed their inhibitory potential for
CHIKV, which was determined
through cytopathic effect assay and plaque reduction assay, which
show inhibition up to 95 and 92% for 70 μM concentration of
the compounds, respectively. The quantitative real-time polymerase
chain reaction assay result confirmed the ability of 5c and 5d to reduce the viral RNA level at 70 μM
concentration
of compounds to nearly 95 and 93% concentration, respectively, in
cells with CHIKV infection. Further, the CHIKV-inhibitory capacity
of these compounds was corroborated by execution of immunofluorescence
assay. The executed work will be meaningful for the future research
of studied dihydrorugosaflavonoids against prime antiviral entrants,
leading to remedial management
to preclude CHIKV infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.